Du er her : Forside > English
 

Innovation and Collaboration: Preparing for and Responding to Global Pandemic Threats

The research-Based Pharmaceutical Industry’s Role.

The Association of the Pharmaceutical Industry in Norway - LMI

Norwegian and foreign pharmaceutical companies selling medicinal products in Norway have their own trade organisation, Legemiddelindustriforeningen (LMI) – The Association of the Pharmaceutical Industry in Norway. LMI is working opposite the authorities, with the image and reputation of the industry, providing services towards the member companies, as well as making case assessments and supplying statistical reports. The association organises courses and training activities, e.g. conducting training courses for medical sales representatives and clinical trial monitors. LMI actively participates in international industry associations for manufacturers of pharmaceutical products.

Norway uses an alternative to drug reference pricing

Article in Scrip.

Rules governing drug information

Updated version of LMI`s Code of Practice.

Recommended guidelines between Patient Organisations and the Pharmaceutical Industry

Implemented as of 1. June 2008.

Value of Vaccines: Two Centuries of Unparalleled Medical Progress

A publication from IFPMA.

New book about the Industrys contribution to the Developing World

IFPMA publishes the new edition of it’s book “Partnerships to Build Healthier Societies in the Developing World”.

Pharma Industry’s contribution to partnership programs to fight serious diseases

The International Federation of Pharmaceutical Manufacturers & Associations, IFPMA, has published four small booklets, each listing the the Pharmaceutical Industry’s contribution to partnership programs in specific therapeutic areas, such as HIV/AIDS, tuberculosis and malaria.

STATUTES of The Norwegian Association of Pharmaceutical Manufacturers

LMIs vedtekter er nå oversatt til engelsk.

EFPIA hilser velkommen EUs analyse av situasjonen for Europas legemiddelindustri

For første gang har EUs ministerråd analysert situasjonen for Europas legemiddelindustri.

Adverse Drug Reaction reports have to be electronically backlogged

Circular 2/2006 from Norwegian Medicines Agency.

Cooperation Agreement RHF-LMI

Guidelines for interaction between doctors, the Norwegian Medical Association and pharmaceutical manufacturers

The guidelines are now available in English.

Norwegian LMI withdraws conference support

Article form Scrip March 26th 2004.